Management of needlestick injuries

Clinical Obstetrics and Gynecology

Volumn 44, Issue 2, 2001, Pages 276-288

  Ferreiro, Roxana B ^a   Sepkowitz, Kent A ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; ANTIRETROVIRUS AGENT; BENZODIAZEPINE DERIVATIVE; DIDANOSINE; EFAVIRENZ; INDINAVIR; LAMIVUDINE; LAMIVUDINE PLUS ZIDOVUDINE; NELFINAVIR; NEVIRAPINE; ORAL CONTRACEPTIVE AGENT; PROTEINASE INHIBITOR; STAVUDINE; ZIDOVUDINE;

DISEASE TRANSMISSION; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; MALAISE; NEEDLESTICK INJURY; NEPHROLITHIASIS; OCCUPATIONAL EXPOSURE; PREVALENCE; PROPHYLAXIS; REVIEW; SEROCONVERSION; TREATMENT PLANNING; VIRUS LOAD; VOMITING;

ANTI-HIV AGENTS; DISEASE NOTIFICATION; DISEASE TRANSMISSION, PATIENT-TO-PROFESSIONAL; FEMALE; HIV INFECTIONS; HUMANS; NEEDLESTICK INJURIES; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; RISK FACTORS; UNITED STATES;

EID: 0035033066     PISSN: 00099201     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003081-200106000-00013     Document Type: Review

References (42)

1. HIV exposure risk assessment and prophylactic treatment
2. Needlestick transmission of HTLV-III from a patient infected in Africa
3. A critical review of the literature on sharp injuries: Epidemiology, management of exposures and prevention
4. Update: Provisional public health service recommendations for chemoprophylaxis after occupational exposure to HIV
5. Public health service guidelines for the management of health-care worker exposures to HIV and recommendations for postexposure prophylaxis
6. The risk of occupational human immunodeficiency virus infection in health care workers
7. Epidemiology and reporting of needle-stick injuries at a tertiary cancer center
8. Percutaneous injuries during surgical procedures
9. Evaluation of blunt suture needles in preventing percutaneous injuries among health-care workers during gynecologic surgical procedures: New York City, March 1993-June 1994
10. Risk for occupational transmission of human immunodeficiency virus type-1 (HIV-1) associated with clinical exposures. A prospective evaluation
11. Occupational risk of HIV, HBV, and HSV-2 in health care personnel caring for AIDS patients
12. Incidence and prevalence of human immunodeficiency virus, hepatitis B virus, hepatitis C virus, and cytomegalovirus among health care personnel at risk for blood exposure: Final report from a longitudinal study
13. Surveillance of human immunodeficiency virus infection and zidovudine use among health care workers after occupational exposure to HIV-infected blood: The CDC Cooperative Needlestick Group
14. Surveillance for occupationally acquired HIV infection-United States, 1981-1992
15. Blood and body fluid exposure follow up in the AIDS era: A two-year experience
16. Surveillance of health care workers exposed to blood from patients infected with the human immunodeficiency virus
17. Sexual transmission of HIV
18. A case-control study of HIV seroconversion in health care workers after percutaneous exposure
19. Efficacy of gloves in reducing blood volumes transferred during simulated needlestick injury
20. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment
21. Immune response to human immunodeficiency virus (HIV) in health care workers occupationally exposed to HIV-contaminated blood
22. T-cell response towards HIV in infected individuals with and without zidovudine therapy, and in HIV-exposed sexual partners
23. Cytotoxic T lymphocyte responses in the peripheral blood of children born to human immunodeficiency virus 1-infected mothers
24. HIV-specific T-helper activity in seronegative health care workers exposed to contaminated blood
25. ENV-specific cytotoxic T lymphocyte responses in HIV seronegative health care workers occupationally exposed to HIV-contaminated body fluids
26. Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant
27. Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission
28. Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine
29. Guidelines for isolation precautions in hospitals
30. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment
31. Low levels of HIV-1 infection in cutaneous dendritic cells promote extensive viral replication upon binding to memory CD4+ T cells
32. Prophylaxis for occupational exposure to HIV
33. Cost-effectiveness of chemoprophylaxis after occupational exposure to HIV
34. Human immunodeficiency virus (HIV) postexposure management of health care workers
35. Failures of zidovudine postexposure prophylaxis
36. Simultaneous transmission of human immunodeficiency virus and hepatitis C virus from a needle-stick injury
37. Time course of viremia and antibody seroconversion following human immunodeficiency virus exposure
38. Post-exposure prophylaxis for HIV: Frequency of initiation and completion of newly recommended regimen
39. Perspectives in disease prevention and health promotion semen banking, organ and tissue transplantation, and HIV antibody testing
40. Testing donors of organs, tissues and semen for antibody to human T-lymphotropic virus type III/lymphadenopathy-associated virus